The purpose was to perform a systematic review of clinical assessment methods for classifying Generalized Joint Hypermobility (GJH), evaluate their clinimetric properties, and perform the best evidence synthesis of these methods. Four test assessment methods (Beighton Score [BS], Carter and Wilkinson, Hospital del Mar, RotesQuerol) and two questionnaire assessment methods (Five-part questionnaire [5PQ], Beighton Score-self reported [BS-self]) were identified on children or adults. Using the Consensus-based Standards for selection of health Measurement Instrument (COSMIN) checklist for evaluating the methodological quality of the identified studies, all included studies were rated "fair" or "poor." Most studies were using BS, and for BS the reliability most of the studies showed limited positive to conflicting evidence, with some shortcomings on studies for the validity. The three other test assessment methods lack satisfactory information on both reliability and validity. For the questionnaire assessment methods, 5PQ was the most frequently used, and reliability showed conflicting evidence, while the validity had limited positive to conflicting evidence compared with test assessment methods. For BS-self, the validity showed unknown evidence compared with test assessment methods. In conclusion, following recommended uniformity of testing procedures, the recommendation for clinical use in adults is BS with cut-point of 5 of 9 including historical information, while in children it is BS with cut-point of at least 6 of 9. However, more studies are needed to conclude on the validity properties of these assessment methods, and before evidence-based recommendations can be made for clinical use on the "best" assessment method for classifying GJH.
INTRODUCTION
Generalized joint hypermobility (GJH) is relatively common, occurring in about 2-57% of different populations [Remvig et al., 2007b] . Important reasons for this may be the use of many different clinical assessment methods and criteria for classification and interpretation of GJH by these clinical assessment methods [Remvig et al., 2007a,b] . GJH is characterized by an ability to exceed the joints beyond the normal range of motion in multiple joints, either congenital or acquired [Remvig et al., 2011] . Many individuals with GJH are asymptomatic, which also makes it difficult to accurately estimate the number of people with this condition, as they are not recorded in the health system.
When GJH is accompanied with symptoms, it is defined as a health-related disorder, for example, Joint Hypermobility Syndrome (JHS) or the EhlersDanlos Syndrome-Hypermobile Type (hEDS) with several complications as described below. The two conditions (JHS and hEDS) have very close overlap to the point of being clinically indistinguishable [Tinkle et al., 2009; Remvig et al., 2011] , and in the present study it is referred to as JHS/hEDS. The condition of JHS/hEDS can be defined as an underand often misdiagnosed heritable connective tissue disorder, characterized generally by GJH, complications of joint instability, musculoskeletal pain, skin involvement, and reduced quality of life [Rombaut et al., 2010; Castori et al., 2014; Scheper et al., 2016] . Until now, JHS is diagnosed by the Brighton tests and criteria [Grahame et al., 2000] , and hEDS by the Villefranche criteria [Beighton et al., 1998 ], both including the Beighton scoring (BS) system of nine tests for assessment of GJH [Beighton et al., 1973] .
BS consists of four bilateral tests and one test including low back and lower extremities (first finger opposition, fifth finger extension, elbow extension, knee extension, and back forward bending), with scores ranging from 0 to 9. Influencing factors on BS are age, gender, ethnicity, and physical fitness [Remvig et al., 2007b; Tinkle et al., 2009] . For adults, a cut-point of 4/9 for GJH is included in the Brighton criteria for JHS [Grahame et al., 2000] , while 5/9 for GJH is the criteria for hEDS in the Villefranche criteria [Beighton et al., 1998 ]. For children, there is no consensus on a specific cut-point for GJH, but cutpoints of 5/9, 6/9, and 7/9 have been suggested [Jansson et al., 2004] . A previous review has listed different test assessment methods of which the Beighton score [Beighton et al., 1973] was most frequently used. The review concluded that reproducibility of Beighton or similar tests is good, but there is lack of evidence for the validity of this test assessment method [Remvig et al., 2007a] .
For adults, a cut-point of 4/9 for GJH is included in the Brighton criteria for JHS, while 5/9 for GJH is the criteria for hEDS in the Villefranche criteria. For children, there is no consensus on a specific cut-point for GJH, but cut-points of 5/9, 6/9, and 7/9 have been suggested.
Further, also questionnaire assessment methods are used for classifying GJH, among which the five-part questionnaire (5PQ) [Hakim and Grahame, 2003; Mulvey et al., 2013] . The 5PQ, so far used only for adults, consists of five questions, including actual and historical information about joint hypermobility (forward bending of the back, first finger opposition, the ability to amuse friends with strange body shapes, dislocation of shoulder/knee, perception of being double-jointed). The 5PQ is claimed to have good reproducibility, in addition to satisfactory sensitivity and specificity [Hakim and Grahame, 2003 ]. However, clinimetric properties (reliability, different aspects of validity, and responsiveness) have not been described fully for BS, 5PQ, or other potential clinical assessment methods for classifying GJH.
Clear and valid diagnostic clinical assessment methods and criteria for classifying GJH with or without symptoms are essential, both for diagnosing JHS/hEDS and measuring treatment effects of JHS/hEDS, in children [Scheper et al., 2013] as well in adults [Palmer et al., 2014; Smith et al., 2014; Scheper et al., 2016] . In summary, there is lack of knowledge of clinimetric properties on clinical assessment methods for classifying GJH. Therefore, the purpose of this study was to perform a systematic review for identifying the clinical assessment methods for classifying GJH, to evaluate their clinimetric properties (reliability and validity), and finally to summarize the best evidence synthesis of these clinical assessment methods.
MATERIALS AND METHODS
This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement guidelines, PRISMA, [Moher et al., 2009] and used the PICOS method to present the chosen research questions: Participants (humans with GJH and healthy controls, ranging from childhood to adults), Intervention (assessment methods for evaluation and classification of GJH), Comparison (e.g., healthy control groups), Outcomes (reliability/ validity), and Study design (e.g., reliability/case control/longitudinal studies).
The overall method used in this review can be divided into four steps: (1) Compile an exhaustive list of assessment methods for GJH on the basis of an initial search (Search 1); (2) Additional search for studies including clinimetrics of the identified assessment methods from Search 1 (Search 2); (3) Critically appraisal of the methodological quality of the identified measurement properties in each study; and (4) synthesizing of the evidence as "a best evidence synthesis."
Selection Criteria

Search 1
With restrictions on the date of publication (January 01, 1965 to December 31, 2015 , humans and English, the included articles had to meet the following criteria: (1) be originally published in peer-reviewed journals involving human participants; (2) include a clinical assessment method (test or questionnaire) to classify GJH; and (3) be reported in English. Studies were excluded if they: (1) contained other advanced assessment methods used as primary assessment method and not as a reference assessment; (2) were reviews, abstracts, theses, unpublished studies ("gray literature"); or (3) were animal studies.
Search 2
By using the names of the different assessment methods found in Search 1, Search 2 was initiated, and the articles were included if they: (1) explicitly outlined a purpose for evaluating clinimetric properties of an assessment method (test or questionnaire) for classifying GJH; and (2) included at least one of the clinimetric properties of reliability, validity, and responsiveness. To avoid confusion in relation to the terminology of clinimetric properties, this study relates to the COSMIN terminology, including reliability (reliability and measurement error), validity (criterion validity and hypotheses testing), and responsiveness [Schellingerhout et al., 2008; Mokkink et al., 2010] .
Search Strategy and Data Sources
Search 1 (production of a list of clinical assessment methods) The systematic review was performed by electronic and manual searches in CI-NAHL (n ¼ 153), Embase (n ¼ 1,027), SportDiscus (n ¼ 272), and MEDLINE (n ¼ 833). Furthermore, reference lists of relevant articles were hand-searched for additional literature, and the authors conferred with experts within the field of GJH, in order to make sure no relevant articles would be missing. In each of the four databases, the following search terms were used for the Electronic Search 1 for producing a method list: (joint Ã ; hypermobility; instability; laxity; general Ã ) AND (evaluation Ã ; rating Ã ; rate Ã ; questionnaire Ã ; test Ã ; scale Ã ; assess Ã ; examin Ã ; observ Ã ; diagnos Ã ; measure Ã ) NOT (fracture Ã ; surgical). The search terms were adjusted to the different databases where necessary. In all databases, the search fields included title, abstract, and keywords.
Search 2 (identifying clinimetric properties)
For the Electronic Search 2, using the same databases as described in Search 1, and with a total of six identified assessment methods at this point, a total of 24 searches were conducted; one in each database, on each assessment method.
The following search terms were used, for retrieving studies with clinimetric properties on each of the six identified assessment methods: (psychometric Ã ; clinimetric Ã ; reproducibility; reliability; repeatability; responsiveness; sensitivity; specificity; validity; diagnos Ã ; feasibility). When including the questionnaire assessment methods, the terms test Ã and tool Ã were left out. See PRISMA flow chart (Fig. 1) for the selection process.
Data Extraction and Quality Assessment
Two authors (KS/BJK) independently screened the titles and abstracts, and agreed upon a final list of assessment methods to be included in the current review. If there were any disagreements, the full paper was retrieved for detailed assessment, and consensus was achieved. A third reviewer (RHE) was included if disagreement still existed. The handling of data were performed with the use of EndNoteWeb (https://www.myendnoteweb.com/), for easy access and organizing of data. Screening for additional references were performed based on the retrieved articles.
Eligible studies for each of the retrieved assessment methods were evaluated by the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) checklist for evaluating the methodological quality on clinimetric properties-reliability, validity, and responsiveness [Mokkink et al., 2010] . The COSMIN checklist is currently the only recommended standardized method [Terwee et al., 2012] , and has been used in several different studies of clinical test assessment methods [Larsen et al., 2014; Kroman et al., 2014] . The complete COSMIN checklist includes 12 boxes, covering internal consistency, reliability, measurement error, validity, and responsiveness. The current study used the reliability and validity domains, in particular box B-reliability (14 items), box F-hypothesis testing (10 items), and box H-criterion validity (7 items). After inclusion of studies, these were grouped based on the clinimetric property assessed, in reliability (intra-, inter-tester and test-retest) and validity (hypothesis testing or criterion validity).
No studies on the responsiveness domain were obtained.
A compiled list for the assessment of the item "minor methodological flaws" as used previously [Larsen et al., 2014] was included (no inclusion of the target population, only for reliability domain; only one trial per measurement/lack of information on repetition; no random order of investigators/measurements; no description of any training phase; inadequate description on demographic details). For the item "other important methodological flaws" an additional list was included (inadequately described/lacking of information about subject eligibility criteria; doubt regarding the site of measurement). Final scoring of the methodological quality of each items, evaluated on a four-point scoring system, (excellent, good, fair, and poor methodological quality) was based on the "worse score counts method" in the checklist [Terwee et al., 2012] .
Finally, a best evidence synthesis was performed, by compiling the assessment of the methodological quality, the actual results of the included studies, the number of studies, and the total sample size, as outlined in connection to the COSMIN evaluation [Terwee et al., 2007] , and as also performed in a previous study [Kroman et al., 2014] . The rating of the best evidence synthesis ranged from strong, moderate, limited, positive/negative, conflicting, or unknown. A note was made whenever a study was rated "poor" due to only one single item. In the reliability domain this mainly concerned the item "only one measurement" (in box B), as often used in clinical examinations and always in questionnaire studies; in the validity domain studies were mainly rated "poor" due to one rating based on the item "no information on the measurement properties of the comparator instrument(s)"; in addition, a note was made to studies rated "poor" due to "subject eligibility criteria inadequately described/lacking." Studies rated "poor" due to only one "poor" item were upgraded to "fair," in line with previous systematic reviews, describing the limitations of the COSMIN when used for clinical test assessment methods [Kroman et al., 2014; Larsen et al., 2014] .
Studies with more than one "poor"-rated item were omitted from the final evidence synthesis.
RESULTS
Identification of Clinical Assessment Methods
In total 2,285 references were identified, and after removal of duplicates 1,338 references were included in the screening procedure of titles and abstracts, of which 298 full-text articles were eligible according to the inclusion criteria. In Search 1, a total of six primary clinical assessment methods for classifying GJH were identified, corresponding to four test assessment methods (BS, Carter, and Wilkinson [CW] , Hospital del Mar [HdM] , Rotes-Querol [RQ]), and two questionnaire assessment methods (5PQ, Beighton Score self-reported [BS-self] ). In Search 2, 163 references were identified, and after removal of duplicates 33 studies were identified describing the clinimetric properties of the six clinical assessment methods (Fig. 1) .
Clinimetric Properties
Methodological quality in relation to reliability of the four test assessment methods (BS, CW, HdM, and RQ) was evaluated from eleven studies, and 
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reliability of one of the two questionnaire assessment methods (5PQ) was evaluated from two studies, while there were no reliability studies on BS-self (Table I ). Methodological quality in relation to validity of the four test assessment methods (BS, CW, HdM, RQ), was evaluated from twenty studies, and validity of the two questionnaire assessment methods (5PQ, BS-self) was evaluated from six studies (Table II) .
All four tests were rated as having poor quality in all reliability studies, while 64% (7 of 11) for BS, and 50% (1 of 2) for RQ could be upgraded to fair quality, when one rating ("only one measurement") was omitted. Both studies of 5PQ were rated as having poor quality in testretest reliability [Moraes et al., 2011; Bulbena et al., 2014] , but both could be upgraded to fair. CW, RQ, and HdM were all rated as having fair quality (3/3), while for BS 82% (14/17) were upgraded and thus rated as having fair quality. All studies on validity for the two questionnaire assessment methods (for 5PQ: 5/5; for BS-self: 1/1) were upgraded, and therefore, rated as fair (Table III) .
As seen in Tables I and II , all test assessment methods BS, CW, HdM, and RQ, have been tested for reliability, and for validity when compared with each other. BS has further been tested for different validity types, such as range of motion (ROM), associations with pain, injuries, and other diseases, whereas HdM has further been tested for validity on associations with shoulder injuries. 5PQ is the only one of the questionnaire assessment methods that has been tested for reliability, and for validity when compared with test assessment methods, associations with pain, diseases, and anxiety. BS-self has only been tested for validity compared with BS (Table III) .
Best Evidence Synthesis: Levels of Evidence
Test assessment methods Of the 11 reliability studies for test assessment methods, 5 studies had poor ratings on methodological quality [Bulbena et al., 1992; Mikkelsson et al., 1996; Hansen et al., 2002; Boyle et al., 2003; Aslan et al., 2006] , and since they could not be upgraded to fair, they were not included in the best evidence synthesis. For the only two studies including intra-rater reliability on BS there was limited positive evidence [Erkula et al., 2005; Hirsch et al., 2007] (Table IV) .
For inter-rater reliability four studies had limited positive evidence [Hicks et al., 2003; Erkula et al., 2005; Hirsch et al., 2007; Juul-Kristensen et al., 2007] , while two studies had negative evidence [Karim et al., 2011; Junge et al., 2013] , leaving the final evidence as limited positive to conflicting evidence. A total of four out of the eleven studies included children [Mikkelsson et al., 1996; Hansen et al., 2002; Erkula et al., 2005; Junge et al., 2013] .
Validity of BS compared with other test assessment methods showed limited positive to conflicting evidence in three studies [Bulbena et al., 1992; Ferrari et al., 2005; Junge et al., 2013] , while compared with ROM (trunk rotation, lower, and upper extremities) the validity in five studies showed limited negative to conflicting evidence (two on children) [Sauers et al., 2001; Erkula et al., 2005; Pearsall et al., 2006; Smits-Engelsman et al., 2011; Naal et al., 2014] . The validity for BS and the association with pain showed moderate positive to conflicting evidence in five studies (all on children) [El-Metwally et al., 2004 , Tobias et al., 2013 Sohrbeck-Nøhr et al., 2014] . For the validity of BS and the association with injuries the validity showed conflicting evidence in three studies (one in children) [Roussel et al., 2009; Cameron et al., 2010; Junge et al., 2015] . For the validity of BS and the association with different diseases (Temporo-Mandibular Disorders, Chronic Fatigue Syndrome, Adhesive Capsulitis) there was limited positive to conflicting evidence in three studies [Nijs et al., 2004; Hirsch et al., 2008; Terzi et al., 2013] .
CW (almost similar to the BS), and RQ had unknown evidence for both inter-rater reliability and validity compared with other test assessment methods [Bulbena et al., 1992] , while HdM showed unknown evidence for inter-rater reliability and validity in the association with injuries, such as anterior shoulder dislocation [Bulbena et al., 1992; Chahal et al., 2010] .
Questionnaire assessment methods
For reliability 5PQ showed conflicting evidence in the two studies [Moraes et al., 2011; Bulbena et al., 2014] . For the validity 5PQ showed limited positive to conflicting evidence compared with test assessment methods (BS, HdM) in the same two studies, while in the association with pain and tissue diseases (chronic widespread pain, JHS) 5PQ showed limited positive evidence in two studies [Hakim and Grahame, 2003; Mulvey et al., 2013] , and with anxiety it showed unknown evidence [Sanches et al., 2014] . BS-self showed unknown evidence in the validity compared with BS in one study [Naal et al., 2014] .
DISCUSSION
Four test assessment methods (BS, CW, HdM, RQ) and two questionnaire assessment methods (5PQ, BS-self) were identified for classifying GJH, in children and adults, with 33 studies reporting their measurement properties. The four test assessment methods and one of the questionnaire assessment methods (5PQ) reported measurement properties on both reliability and validity. Most studies were on BS, and only BS and 5PQ reported aspects of validity.
Four test assessment methods (BS, CW, HdM, RQ) and two questionnaire assessment methods (5PQ, BS-self) were identified for classifying GJH, in children and adults, with 33 studies reporting their measurement properties.
The majority of the reliability studies showed limited positive to conflicting evidence for BS, and thus, may seem acceptable to be used in clinical 
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practice, provided that uniformity of testing procedures is included in testing procedures, in addition to historical information, especially in adults. However, there are shortcomings on studies for the validity of BS, while the three other test assessment methods lack information on both reliability and validity. For the questionnaire assessment methods, 5PQ was the most frequently used, however, only in adult population studies, and the reliability showed conflicting evidence. Concerning the validity there were shortcomings on studies for 5PQ, while for BS-self the validity showed unknown evidence in comparison with BS. More studies are needed to conclude on the measurement properties for BS-self.
Inter-rater reliability studies on test assessment methods were most frequently reported on BS, with the majority showing limited positive to conflicting evidence, and thus, may be acceptable for this assessment method. This may provide useful information for clinicians and researchers, in order to establish uniformity in carrying out the procedures. On the other hand, it also shows the need for more future comprehensive studies of this test assessment method, since unclear/vague or different descriptions of the procedures for performing the Beighton tests were used (e.g., thumbs apposition with straight or flexed elbow, knee extension in standing or supine lying). The procedures initially illustrated by photos for performing the Beighton tests [Beighton et al., 1973] are recommended for future clinical use, as described in detail in the appendix of one of the reliability studies [Juul-Kristensen et al., 2007] , as they have satisfactory reliability.
Some of the studies did not include all nine tests as recommended, which especially is important when defining cut-points for classifying GJH, as discussed further below. Other test assessment methods, such as CW, RQ, and HdM showed unknown evidence on reliability in one single study [Bulbena et al., 1992] , which is too limited to conclude on.
For the questionnaire assessment methods, most of the studies were The current review demonstrates cut-points varying for the different clinical assessment methods. In the adult population, when using nine tests for BS, mostly one cut-point was used for classifying GJH varying between 4 and 6, but one study used 2/9 [Cameron et al., 2010] . However, also two cut-points were used, with a lower cut-point for "tight/not hypermobile" individuals varying between 1 and 4, and an upper cut-point for "hypermobile/extremely hypermobile" individuals varying between 4 and 7 [Boyle et al., 2003; Aslan et al., 2006; Hirsch et al., 2008; Roussel et al., 2009] . For the questionnaire assessment methods only one cut-point was used for classifying GJH, varying between 2 and 3 and with a different total score varying between 5 and 7 [Hakim and Grahame, 2003; Bulbena et al., 2014] .
Generally, for adults, one cutpoint, varying from 4 to 5 was used in BS (4/9 and 5/9), and 2/5 in 5PQ have been used. For children, one cutpoint varying from 5 to 7 was used in Inter: Unknown Unknown continued BS (5/9, 6/9, and 7/9). In one test assessment method the total score was 11 with a cut-point of 7/11 for classifying GJH based on only tests in the lower extremities [Ferrari et al., 2005] , and another study used two cutpoints the lower being 5/9 and the upper being 7/9 [Smits-Engelsman et al., 2011] . Since JHS and hEDS in the current review are recognized as one and the same condition, a specific cut-point needs to be decided, and 5/9 may be suggested for future use in adults. However, since joint mobility, and therefore, BS is known to decrease by age [Remvig et al., 2007b] , there is a need for adults also to include additional historical information, as described in the appendix of the reliability study using the BS, with phrasing "can you now or have you previously been able to . . . " [JuulKristensen et al., 2007] , and in the study describing 5PQ [Hakim and Grahame, 2003 ].
Generally, for adults, one cutpoint, varying from 4 to 5 was used in BS (4/9 and 5/9), and 2/5 in 5PQ have been used. For children, one cut-point varying from 5 to 7 was used in BS (5/9, 6/9, and 7/9).
Since children have individual growth periods, this may be the reason for using two cut-points (a lower and an upper) as recently suggested [SmitsEngelsman et al., 2011] , and therefore, the upper cut-point is suggested to be at least 6/9 as used in previous population studies [El-Metwally et al., 2004 Tobias et al., 2013] .
Warming-up before performing flexibility tests may influence the outcome of a test assessment method. However, almost no studies reported whether participants did warm-up, and , Superscripts shows year of publication. Ã Reliability studies rated poor on the basis of one single rating, based on "only one measurement." ÃÃ Validity studies rated poor on the basis of one single rating "no information on the measurement properties of the comparator instrument(s)."
the influence of such performance is therefore, unknown.
This review highlights a number of areas warranting future research. Because of the limited studies on the clinical assessment methods for classifying GJH, more high quality studies, and especially those evaluating aspects of validity are required (concurrent, predictive, measurement error, responsiveness, and interpretability). Additional clinical test assessment methods may further be considered in order to support and endorse the presence of GJH in the diagnostic procedure of heritable connective tissue disorders. Also of importance is that consensus is warranted regarding selection of specific test and questionnaire assessment methods for classifying GJH, the test performance, and the cut-points by which age, gender, and ethnicity may be taken into account.
Limitations of the study are the small amount of studies, for which reason it was decided only to rate reliability (intra-and inter-rater) and validity (hypothesis testing or criterion validity). Use of COSMIN is recommended to be the best evaluation method until now, as has also been used previously to evaluate clinical test assessment methods [Kroman et al., 2014; Larsen et al., 2014] . However, since the COSMIN originally was designed for the evaluation of patient-reported outcomes, there are some adjustments that need to be considered when using COSMIN for clinical test assessment methods. For example, although rating of the number of measurements taken may be useful in settings with continuous scales as in performance-based methods, rating scales in many clinical assessment methods (test or questionnaire) are dichotomous (positive/negative). To adjust for this shortcoming, the present review adjusted the evaluation of methodological quality, corresponding to when "only one measurement" was rated poor in reliability, the study was upgraded from poor to fair, meaning that the study thereby could be included in the best evidence synthesis. Furthermore, the sample size in clinical studies is often much smaller than in questionnaire studies, and therefore, it may be suggested that minor sample sizes should not be rated that strictly as in questionnaire assessment methods, when studying clinical test assessment methods. For validity studies, one poor rating including "no information on the measurement properties of the comparator instrument" or "subject eligibility criteria inadequately described/lacking," allowed upgrading to fair, and the study could thereby be included in the best evidence synthesis.
Strengths of this review are the systematic and rigid use of recommended strategies for systematic reviews of clinical assessment methods, the evaluation of their clinimetric properties and rating of the best evidence synthesis.
CONCLUSION
In the current review, four test and two questionnaire assessment methods for classifying GJH were found with measurement properties of varying methodological strength and results of varying weight. Most of the studies used the BS. The inter-rater reliability of this method seems acceptable to be used in clinical practice, provided that uniformity of testing procedures are included in the testing procedures, in addition to historical information, especially in adults. However, shortcomings were found in studies on the validity of BS, while the three other test assessment methods (CW, RQ, HdM) lack satisfactory information on both reliability and validity. Regarding questionnaire assessment methods, 5PQ is the most frequently method used, however, only in adult population studies. In conclusion provided uniformity of testing procedures, the recommendation for clinical use in adults is BS with cut-point of 5 of 9 including historical information, while in children it is BS with cut-point of at least 6 of 9. However, more studies are needed to conclude, especially on the validity properties of these assessment methods, and before evidencebased recommendations can be made for clinical use on the "best" assessment method for classifying GJH.
In the current review, four test and two questionnaire assessment methods for classifying GJH were found with measurement properties of varying methodological strength and results of varying weight. Most of the studies used the BS.
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